Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study
Title:
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study
Author:
Hurwitz, Barrie J. Jeffery, Douglas Arnason, Barry Bigley, Kim Coyle, Patricia Goodin, Douglas Kaba, Samer Kirzinger, Stephen Lynch, Sharon Mandler, Raul Mikol, Daniel Rammohan, Kottil Sater, Richard Sriram, Subramaniam Thrower, Ben Boateng, Francis Jakobs, Peter Wash, Mary Beth Bogumil, Timon